CorVel Co. (NASDAQ:CRVL) Shares Sold by Cynosure Group LLC

Cynosure Group LLC lessened its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 24.7% in the third quarter, Holdings Channel.com reports. The firm owned 1,143 shares of the business services provider’s stock after selling 374 shares during the period. Cynosure Group LLC’s holdings in CorVel were worth $374,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its holdings in CorVel by 13.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,094 shares of the business services provider’s stock worth $1,992,000 after acquiring an additional 734 shares in the last quarter. FMR LLC grew its stake in CorVel by 193.1% in the third quarter. FMR LLC now owns 4,306 shares of the business services provider’s stock worth $1,408,000 after purchasing an additional 2,837 shares in the last quarter. Cerity Partners LLC bought a new stake in CorVel in the third quarter valued at about $773,000. Citigroup Inc. raised its stake in CorVel by 68.5% during the third quarter. Citigroup Inc. now owns 11,662 shares of the business services provider’s stock valued at $3,812,000 after buying an additional 4,742 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in CorVel by 7.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 86,236 shares of the business services provider’s stock worth $28,190,000 after buying an additional 6,061 shares during the last quarter. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded CorVel from a “buy” rating to a “hold” rating in a report on Saturday, August 31st.

CorVel Stock Performance

Shares of NASDAQ:CRVL opened at $361.39 on Friday. The company’s fifty day moving average is $328.11 and its two-hundred day moving average is $297.16. CorVel Co. has a 1-year low of $203.90 and a 1-year high of $381.73. The stock has a market capitalization of $6.19 billion, a price-to-earnings ratio of 76.73 and a beta of 1.10.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.